Pascal Touchon, President and CEO at Atara Biotherapeutics, Inc. (ATRA), sold 163,012 shares at $0.62 ($101K) on 2024-05-16, disclosed to the SEC on 2024-05-20.
Seasonal sale ($101k) by President and CEO — this insider has traded ATRA in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.62 | 81,506 | $51K | 50.0% |
| 2 | $0.62 | 81,506 | $51K | 50.0% |
| Total | $0.62 avg | 163,012 | $101K | 100% |
| Filing → |
| ATRA | SELL | 2023-11-20 | $8K | — | Filing → |
| ATRA | SELL | 2023-08-18 | $51K | — | Filing → |
| ATRA | SELL | 2023-06-29 | $24K | — | Filing → |